RhoGDI2 is an invasion and metastasis suppressor gene in human cancer

John J. Gildea, M. Jabed Seraj, Gary Oxford, Michael A. Harding, Garret M. Hampton, Christopher A. Moskaluk, Henry F. Frierson, Mark R. Conaway, Dan Theodorescu

Research output: Contribution to journalArticlepeer-review

217 Scopus citations


To discover novel metastasis suppressor genes that are clinically relevant in common human cancers, we used isogenic human bladder cancer cell lines and used DNA microarray technology to identify genes whose expression diminishes as a function of invasive and metastatic competence. We then evaluated the expression profile of such genes in 105 pathologically characterized tumors from seven common organ sites, and we identified one gene, RhoGDI2, whose expression was diminished as a function of primary tumor stage and grade. When RhoGDI2 was transferred back into cells with metastatic ability that lacked its expression, it suppressed experimental lung metastasis but did not affect in vitro growth, colony formation, or in vivo tumorigenicity. In addition, RhoGDI2 reconstitution in these cells blocked invasion in an organotypic assay and led to a reduction of in vitro motility. These results indicate that RhoGDI2 is a metastasis suppressor gene, a marker of aggressive human cancer, and a promising target for therapy.

Original languageEnglish
Pages (from-to)6418-6423
Number of pages6
JournalCancer Research
Issue number22
StatePublished - 15 Nov 2002
Externally publishedYes


Dive into the research topics of 'RhoGDI2 is an invasion and metastasis suppressor gene in human cancer'. Together they form a unique fingerprint.

Cite this